VIP (10mg)
Specifiche tecniche
| Purezza (HPLC) | ≥95% (HPLC) |
| Numero CAS | 37221-79-7 |
| Forma | White lyophilized powder |
| Conservazione | -20°C |
| Sequenza | His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH₂ |
| Peso molecolare | 3,326.82 g/mol |
| Forma salina | Acetate |
| Solubilità | Soluble in water |
VIP (10mg)
Prezzo di listino EUR · HU, SK, CZ, PL
- Eurozone (EUR)144,00 EUR
- Ungheria (HU)144,00 EUR≈ 57 600 Ft
- Slovacchia (SK)144,00 EUR
- Cechia (CZ)144,00 EUR≈ 3 600 Kč
- Polonia (PL)144,00 EUR≈ 612,00 zł
Stesso prezzo di listino in EUR per consegna in Ungheria, Slovacchia, Repubblica Ceca e Polonia. Pagamento in EUR.
HUF/CZK/PLN indicativi convertiti da EUR; la Slovacchia usa EUR. Tassi approssimativi. Pagamento in EUR.
Vasoactive Intestinal Peptide — 28-amino-acid neuropeptide for inflammation and vascular research. 10mg vial.
Solo per ricerca di laboratorio.
Non destinato al consumo umano, uso veterinario o diagnostico.
From the Peptide Explorer
A 28-amino-acid neuropeptide found throughout the central and peripheral nervous systems, GI tract, and immune cells. VIP acts on VPAC1 and VPAC2 receptors to mediate vasodilation, smooth muscle relaxation, immune regulation, and neuroprotection across multiple organ systems.
Key Mechanisms
- ›VPAC1/VPAC2 receptor agonism
- ›Vasodilation via cAMP
- ›Anti-inflammatory cytokine regulation
- ›Neuroprotective signaling
- ›Smooth muscle relaxation
Primary Research Areas
- ›Neuroprotection
- ›Autoimmune disease
- ›Lung protection
- ›GI motility
- ›Vasodilation
Key Research Findings
- Demonstrated neuroprotective effects in Parkinson's and Alzheimer's models
- Aviptadil (synthetic VIP) advanced to clinical trials for ARDS
- Potent anti-inflammatory effects in autoimmune disease models
Research Overview
A 28-amino-acid neuropeptide found throughout the central and peripheral nervous systems, GI tract, and immune cells. VIP acts on VPAC1 and VPAC2 receptors to mediate vasodilation, smooth muscle relaxation, immune regulation, and neuroprotection across multiple organ systems.
Origin: Discovered in porcine intestinal extracts by Said & Mutt, 1970
Mechanism of Action
- VPAC1/VPAC2 receptor agonism
- Vasodilation via cAMP
- Anti-inflammatory cytokine regulation
- Neuroprotective signaling
- Smooth muscle relaxation
Primary Research Areas
- Neuroprotection
- Autoimmune disease
- Lung protection
- GI motility
- Vasodilation
Key Published Findings
- Demonstrated neuroprotective effects in Parkinson's and Alzheimer's models
- Aviptadil (synthetic VIP) advanced to clinical trials for ARDS
- Potent anti-inflammatory effects in autoimmune disease models
Research Protocol
Commonly studied routes: Intravenous, Subcutaneous, Intranasal. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized
Important Notice
VIP (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specifiche di ricerca
Synthesized for strict analytical consistency. Verified via HPLC/MS.Vedi standard qualità →
Manipolazione e conservazione
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water